American Association of Individual Investors5d
Why Structure Therapeutics Inc.’s (GPCR) Stock Is Down 12.27%
Structure Therapeutics Inc.’s GPCR share price has dipped by 12.27%, which has investors questioning if this is right time to buy.
JD Supra2d
End of the Road for Jepson Format Claims in the Life Sciences?
Xencor, Inc., the US Court of Appeals for the Federal Circuit confirmed that the limiting preamble of a Jepson claim must be supported ...
University of Illinois at Urbana–Champaign3d
Nobels & Pulitzers
(1922–1993) won the Nobel Prize in medicine and physiology in 1968 for his work determining the precise structure of nucleic acids ... especially for achieving the first synthesis of a polypeptide ...
eLife3d
Viral-mediated Oct4 overexpression and inhibition of Notch signaling synergistically induce neurogenic competence in mammalian Müller glia
This manuscript demonstrates that Oct4 overexpression synergizes with Notch inhibition (Rbpj knockout) to promote the conversion of adult murine Müller glia (MG) into bipolar cells. These findings are ...
Horizon Kinetics Holding Corporation (HKHC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call April 2, 2025 4:15 PM ET. Company Participants. Murray Stahl - Chairman, CEO, Chief Investment O ...
Nature2d
Protein folding articles from across Nature Portfolio
Protein folding is the process by which proteins achieve their mature functional (native) tertiary structure, and often begins co-translationally. Protein folding requires chaperones and often ...